Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymidine kinase in malignant melanoma

J Borovanský1, J Stríbrná, M Elleder

  • 1Department of Biochemistry, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Melanoma Research
|October 1, 1994
PubMed
Summary

Serum thymidine kinase levels may indicate melanoma progression and treatment effectiveness. This study measured thymidine kinase (TK) activity in melanoma models, finding it a potential biomarker for monitoring therapy outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2015
Same author

[Immunoscore and Its Predictive Value for Colorectal Cancer].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2015
Same author

[In Process Citation].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2015
Same author

Pregnane xenobiotic receptors and their effect on drug elimination from the organism.

Prague medical report·2014
Same author

Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaT.

TheScientificWorldJournal·2012
Same author

[Prenatal diagnosis of lysosomal enzymopathies in the Czech Republic].

Casopis lekaru ceskych·2012

Area of Science:

  • Biochemistry
  • Oncology
  • Enzymology

Background:

  • Thymidine kinase (TK) is crucial for DNA synthesis and elevated in proliferating cells.
  • TK is a known marker for various cancers but uninvestigated in melanoma.
  • Melanoma models are essential for understanding disease progression and therapeutic responses.

Purpose of the Study:

  • To evaluate thymidine kinase activity as a potential biomarker in melanoma.
  • To assess TK levels in relation to tumor proliferation and pigmentation in B16 and Cloudman S91 melanoma models.
  • To determine if serum TK levels can reflect the efficacy of melanoma therapy.

Main Methods:

  • Radioenzymic assay used to measure thymidine kinase activity in tumor cytosols and serum.
  • Histochemical assessment of proliferating cell nuclear antigen (PCNA) for tumor proliferation.

Related Experiment Videos

  • Comparison of TK levels between melanoma-bearing mice and healthy controls, including cyclophosphamide-treated groups.

    • Main Results:

    • Higher tumor cytosolic TK activity observed in Cloudman S91 melanoma compared to B16 melanoma, relative to proliferation.
    • Elevated serum TK levels detected in both B16 and Cloudman S91 melanoma-bearing mice versus controls.
    • Cyclophosphamide treatment in B16 melanoma-bearing mice led to significantly lower serum TK levels compared to untreated mice.

    Conclusions:

    • Serum thymidine kinase levels show potential as a non-invasive marker for monitoring melanoma therapy efficacy.
    • TK activity correlates with tumor characteristics and proliferative status in experimental melanoma models.
    • Further research into serum TK as a melanoma biomarker is warranted.